Verano Holdings (VRNO) Amortizatization of Intangibles (2021 - 2026)
Verano Holdings (VRNO) reported Amortizatization of Intangibles of $3.0 million for Q1 2026, up 1.52% year-over-year from $3.0 million in Q1 2025, and little changed quarter-over-quarter from $3.0 million in Q4 2025.
Verano Holdings (VRNO) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Amortizatization of Intangibles data on file, last reported at $3.0 million in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $3.0 million, up 1.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.0 million (up 7.2% YoY), and the FY2025 annual result was $12.0 million, up 7.1% from the prior year.
- Amortizatization of Intangibles was little changed at $3.0 million in Q1 2026 per VRNO's latest filing, from $3.0 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $3.9 million in Q2 2024 and troughed at $1.7 million in Q4 2024.
- A 5-year average of $2.7 million and a median of $2.6 million in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles surged 167.88% in 2022, then tumbled 34.9% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $2.5 million in 2022, then gained by 7.64% to $2.7 million in 2023, then plunged by 34.9% to $1.7 million in 2024, then jumped by 74.5% to $3.0 million in 2025, then slipped by 0.46% to $3.0 million in 2026.
- Business Quant data shows VRNO's Amortizatization of Intangibles at $3.0 million in Q1 2026, $3.0 million in Q4 2025, and $3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Verano Holdings | - | - | 98.98 Mn | 3.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.01 Mn |
| Mar 31, 2026 | 3.01 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Jun 30, 2025 | 3.01 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Dec 31, 2024 | 1.73 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Jun 30, 2024 | 3.88 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Dec 31, 2023 | 2.66 Mn |